Neuromedin U receptors


More information on this family may be found on the IUPHAR-DB family and introduction pages.


Overview « Hide

Neuromedin U receptors (provisional nomenclature) are activated by the endogenous 25 amino acid peptide neuromedin U (NMU-25, NMU), a peptide originally isolated from pig spinal cord [9]. In humans, NMU-25 appears to be the sole product of a precursor (ENSG00000109255) showing a broad tissue distribution, but which is expressed at highest levels in the upper gastrointestinal tract, CNS, bone marrow and fetal liver. Much shorter versions of NMU are found in some species, but not human, and are derived at least in some instances from the proteolytic cleavage of the longer NMU. Despite species differences in NMU structure, the C-terminal region (particularly the C-terminal pentapeptide) is highly conserved and contains biological activity. Neuromedin S (NMS-33) has also been identified as an endogenous agonist [10]. NMS-33 is a 36 amino-acid product of a precursor protein derived from a single gene (ENSG00000204640) and contains an amidated C-terminal heptapeptide identical to NMU. NMS-33 appears to activate NMU receptors with equivalent potency to NMU-25.


Unless otherwise stated all data refer to the human proteins. Gene information is provided for human (Hs), mouse (Mm) and rat (Rn).

Receptors

NMU1 receptor Show »

NMU2 receptor Show »


Comments Show »

Further Reading Show »

References Show »